Hepatocellular Hypertrophy and Cell Proliferation in Sprague-Dawley Rats Following Dietary Exposure to Ammonium Perfluorooctanoate Occurs through Increased Activation of the Xenosensor Nuclear Receptors PPARα and CAR/PXR
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Ammonium perfluorooctanoate (APFO), a processing aid used in the production of fluoropolymers, produces hepatomegaly and hepatocellular hypertrophy in rodents. In mice, APFO-induced hepatomegaly is associated with increased activation of the xenosensor nuclear receptors, PPARα and CAR/PXR. Although non-genotoxic, chronic dietary treatment of Sprague-Dawley (S-D) rats with APFO produced an increase in benign tumours of the liver, acinar pancreas, and testicular Leydig cells. Most of the criteria for establishing a PPARα-mediated mode of action for the observed hepatocellular tumours have been previously established with the exception of the demonstration of increased hepatocellular proliferation. The present study evaluates the potential roles for APFO-induced activation of PPARα and CAR/PXR with respect to liver tumour production in the S-D rat and when compared to the specific PPARα agonist, 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (Wy 14,643). Male S-D rats were fed APFO (300 ppm in diet) or Wy 14,643 (50 ppm in diet) for either 1, 7, or 28 days. Effects of treatment with APFO included: decreased body weight; hepatomegaly, hepatocellular hypertrophy, hepatocellular hyperplasia (microscopically and by BrdU labelling index), and hepatocellular glycogen loss; increased activation of PPARα (peroxisomal β-oxidation and microsomal CYP4A1 protein); decreased plasma triglycerides, cholesterol, and glucose; increased activation of CAR (CYP2B1/2 protein) and CAR/PXR (CYP3A1 protein). Responses to treatment with Wy 14,643 were consistent with increased activation of PPARα, specifically: increased CYP4A1 and peroxisomal β-oxidation; increased hepatocellular hypertrophy and cell proliferation; decreased apoptosis; and hypolipidaemia. With the exception of decreased apoptosis, the effects observed with Wy 14,643 were noted with APFO, and APFO was less potent. These data clearly demonstrate an early hepatocellular proliferative response to APFO treatment and suggest that the hepatomegaly and tumours observed after chronic dietary exposure of S-D rats to APFO likely are due to a proliferative response to combined activation of PPARα and CAR/PXR. This mode of action is unlikely to pose a human hepatocarcinogenic hazard.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, these compounds appear to exert toxicological effects by binding to and activating the peroxisome proliferator receptor alpha (PPARα), a transcription factor that regulates lipid metabolism, energy balance and inflammation [28,29,30,31].”
From The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science (2023) · cites this paper as [28]
In the citing paper
“However, PPARα activators are unlikely to cause liver tumors in humans due to differences in biological response to PPARα activation in key downstream events [28,32,33].”
From The EU’s Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science (2023) · cites this paper as [28]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331 · cited 1×
“The protein concentration of tissue heavy pellets was determined in aqueous solutions using a modiWcation of the method of Lowry et al. (1951) and bovine serum albumin”
MethodBurton, K. (1956) · Biochemical Journal · doi:10.1042/bj0620315 · Cited by 14,090
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620 · cited 1×
“The toxicology of PFOA has been reviewed (Kennedy et al. 2004; Lau et al. 2007 ).”
BackgroundLee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
The toxicology of perfluorooctanoate
Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742
Self-citationThe nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism
Wei, P., Zhang, J., Egan-Hafley, M., Liang, S., & Moore, D. D. (2000) · Nature · doi:10.1038/35038112 · Cited by 654 · cited 1×
“Several studies using receptor KO mice have shown the requirement for active CAR, PXR, or PPAR for the expression of the complete hypertrophic and hyperplastic changes characteristic of liver growth–inducing agents (Lee et al. 1995; Wei et al. 2000; Huang et al. 2005; Scheer et al. 2008).”
BackgroundPPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., et al. (2003) · Critical Reviews in Toxicology · doi:10.1080/713608372 · Cited by 611
Vanden Heuvel, J. P., Thompson, J. T., Frame, S. R., & Gillies, P. J. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl014 · Cited by 479 · cited 2×
“As stated in the introduction, PFOA has been conWrmed to activate and to be a ligand for the xenosensor nuclear receptor PPAR (Bjork and Wallace 2009; Maloney and Waxman 1999; Nakamura et al. 2009; Rosen et al. 2008a; Takacs and Abbott 2007; Vanden Heuvel et al. 2006; Wolf et al. 2008).”
BackgroundTakacs, M. L., & Abbott, B. D. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfl135 · Cited by 396
trans-Activation of PPARα and PPARγ by Structurally Diverse Environmental Chemicals
Maloney, E. K., & Waxman, D. J. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8809 · Cited by 374 · cited 3×
“As stated in the introduction, PFOA has been conWrmed to activate and to be a ligand for the xenosensor nuclear receptor PPAR (Bjork and Wallace 2009; Maloney and Waxman 1999; Nakamura et al. 2009; Rosen et al. 2008a; Takacs and Abbott 2007; Vanden Heuvel et al. 2006; Wolf et al. 2008).”
BackgroundInfluentialYamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., & Maronpot, R. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1459 · Cited by 350 · cited 1×
“Furthermore, a limited number of studies with Car-null and Ppar-null mice have demonstrated that an active receptor is required for liver tumour promotion by phenobarbital and the induction of hepatic tumours by Wy 14,643 (Huang et al. 2005; Morimura et al. 2006; Yamamoto et al. 2004 ).”
BackgroundMechanisms of Extrahepatic Tumor Induction by Peroxisome Proliferators in Male CD Rats
Biegel, L. B., Hurtt, M. E., Frame, S. R., O'Connor, J. C., & Cook, J. C. (2001) · Toxicological Sciences · doi:10.1093/toxsci/60.1.44 · Cited by 349
Doull, J., Cattley, R., Elcombe, C., Lake, B. G., Swenberg, J., Wilkinson, C., Williams, G., & van Gemert, M. (1999) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1999.1296 · Cited by 337 · cited 1×
“This conclusion is supported by cancer mortality studies on therapeutically administered agents such as phenobarbital, and cloWbrate and bezaWbrate, CAR/PXR and PPAR agonists, respectively (Bentley et al. 1993; Doull et al. 1999; Olsen et al. 1989, 1995; Whysner et al. 1996; IARC 2001).”
BackgroundSelf-citationWolf, C. J., Takacs, M. L., Schmid, J. E., Lau, C., & Abbott, B. D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn166 · Cited by 297 · cited 2×
“PFOA has been conWrmed to activate and to be a ligand for the peroxisome proliferator-activated receptor (PPAR) (Bjork and Wallace 2009; Nakamura et al. 2009; Maloney and Waxman 1999; Rosen et al. 2008a; Takacs and Abbott 2007; Vanden Heuvel et al. 2006; Wolf et al. 2008 ).”
BackgroundHuang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., & Moore, D. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0520 · Cited by 284 · cited 2×
“Several studies using receptor KO mice have shown the requirement for active CAR, PXR, or PPAR for the expression of the complete hypertrophic and hyperplastic changes characteristic of liver growth–inducing agents (Lee et al. 1995; Wei et al. 2000; Huang et al. 2005; Scheer et al. 2008).”
BackgroundHepatic peroxisome proliferation in rodents and its significance for humans
Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., & Wiegand, H.-J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90225-n · Cited by 271 · cited 1×
“This conclusion is supported by cancer mortality studies on therapeutically administered agents such as phenobarbital, and cloWbrate and bezaWbrate, CAR/PXR and PPAR agonists, respectively ( Bentley et al. 1993; Doull et al. 1999; Olsen et al. 1989, 1995; Whysner et al. 1996; IARC 2001).”
BackgroundSelf-citationPPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
Gonzalez, F. J., & Shah, Y. M. (2008) · Toxicology · doi:10.1016/j.tox.2007.09.030 · Cited by 262
Toxicity of Ammonium Perfluorooctanoate in Male Cynomolgus Monkeys after Oral Dosing for 6 Months
Butenhoff, J. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.1.244 · Cited by 259
Self-citationShah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M., & Gonzalez, F. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00317-07 · Cited by 255
Berthiaume, J., & Wallace, K. B. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00466-0 · Cited by 246 · cited 1×
“The majority of genes for which mRNA expression levels are changed in response to dosing with PFOA in mice are regulated by PPAR, and many of those not regulated by PPAR are regulated by CAR (Rosen et al. 2008a, b). In addition, PFOA has been shown to increase mitochondrial mass via mitochondrial proliferation in rats…”
BackgroundWhysner, J. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00067-8 · Cited by 233 · cited 1×
“This conclusion is supported by cancer mortality studies on therapeutically administered agents such as phenobarbital, and cloWbrate and bezaWbrate, CAR/PXR and PPAR agonists, respectively (Bentley et al. 1993; Doull et al. 1999; Olsen et al. 1989, 1995; Whysner et al. 1996; IARC 2001).”
BackgroundCheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., & Gonzalez, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0322 · Cited by 215
Rosen, M. B., Lee, J. S., Ren, H., Vallanat, B., Liu, J., Waalkes, M. P., Abbott, B. D., Lau, C., & Corton, J. C. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn025 · Cited by 200
Fatty acid oxidation by human liver peroxisomes
Bronfman, M., Inestrosa, N. C., & Leighton, F. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91512-2 · Cited by 199 · cited 1×
“Biochemical analyses Peroxisome proliferation was evaluated by CN-insensitive acyl CoA oxidation determined spectrophotometrically in liver heavy pellet using palmitoyl CoA as a substrate ( Bronfmann et al. 1979 ).”
MethodMorimura, K., Cheung, C., Ward, J. M., Reddy, J. K., & Gonzalez, F. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi329 · Cited by 168 · cited 1×
“Furthermore, a limited number of studies with Car-null and Ppar-null mice have demonstrated that an active receptor is required for liver tumour promotion by phenobarbital and the induction of hepatic tumours by Wy 14,643 (Huang et al. 2005; Morimura et al. 2006; Yamamoto et al. 2004).”
BackgroundAmmonium Perfluorooctanoate Production and Occupational Mortality
Lundin, J. I., Alexander, B. H., Olsen, G. W., & Church, T. R. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181b5f395 · Cited by 156 · cited 1×
“SpeciWc to APFO, occupational cancer mortality studies have not found increased risk of death from liver cancer among workers occupationally exposed to APFO (Leonard et al. 2008; Lundin et al. 2009 ).”
BackgroundRoss, J., Plummer, S. M., Rode, A., Scheer, N., Bower, C. C., Vogel, O., Henderson, C. J., Wolf, C. R., & Elcombe, C. R. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq118 · Cited by 153
Self-citationLeonard, R. C., Kreckmann, K. H., Sakr, C. J., & Symons, J. M. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.06.011 · Cited by 147 · cited 1×
“SpeciWc to APFO, occupational cancer mortality studies have not found increased risk of death from liver cancer among workers occupationally exposed to APFO ( Leonard et al. 2008; Lundin et al. 2009).”
BackgroundScheer, N., Ross, J., Rode, A., Zevnik, B., Sandra, N., Faust, N., & Wolf, C. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35483 · Cited by 142 · cited 1×
“Several studies using receptor KO mice have shown the requirement for active CAR, PXR, or PPAR for the expression of the complete hypertrophic and hyperplastic changes characteristic of liver growth–inducing agents (Lee et al. 1995; Wei et al. 2000; Huang et al. 2005; Scheer et al. 2008 ).”
BackgroundCancer Among Epileptic Patients Exposed to Anticonvulsant Drugs
Olsen, J. H., Boice, J. D., Jensen, J. P. A., & Fraumeni, J. F. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.10.803 · Cited by 138
Bjork, J. A., & Wallace, K. B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp093 · Cited by 137 · cited 3×
“As stated in the introduction, PFOA has been conWrmed to activate and to be a ligand for the xenosensor nuclear receptor PPAR ( Bjork and Wallace 2009; Maloney and Waxman 1999; Nakamura et al. 2009; Rosen et al. 2008a; Takacs and Abbott 2007; Vanden Heuvel et al. 2006; Wolf et al. 2008).”
BackgroundInfluentialGene Profiling in the Livers of Wild-type and PPARα-Null Mice Exposed to Perfluorooctanoic Acid
Rosen, M. B., Abbott, B. D., Wolf, D. C., Corton, J. C., Wood, C. R., Schmid, J. E., Das, K. P., Zehr, R. D., Blair, E. T., & Lau, C. (2008) · Toxicologic Pathology · doi:10.1177/0192623308318208 · Cited by 132
Pastoor, T. P., Lee, K. P., Perri, M. A., & Gillies, P. J. (1987) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(87)90011-6 · Cited by 93 · cited 1×
“The marked increase in liver mass observed in rodents after treatment with PFOA is believed to be due, in part, to increases in hepatocellular peroxisomes and smooth endoplasmic reticulum as a direct result of activation of xenosensor nuclear receptors such as PPAR, the constitutive androstane receptor (CAR), and the…”
BackgroundLake, B. G. (2009) · Xenobiotica · doi:10.1080/00498250903098184 · Cited by 91 · cited 5×
“In contrast to eVects in primary cultures of rodent hepatocytes, phenobarbital does not appear to induce replicative DNA synthesis in cultured human hepatocytes (Parzefall et al. 1991; Hirose et al. 2009; Lake 2009 ).”
BackgroundInfluentialParzefall, W., Erber, E., Sedivy, R., & Schulte‐Hermann, R. (1991) · PubMed · Cited by 87
Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.
Olsen, J. H., Schulgen, G., Boice, J. D., Whysner, J. A., Travis, L. B., Williams, G. M., Johnson, F. B., & McGee, J. O. (1995) · PubMed · Cited by 84
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants
Pirttiaho, H. I., Sotaniemi, E. A., Pelkonen, R. O., & Pitk�nen, U. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00542550 · Cited by 71 · cited 1×
“Although CAR is present in human liver and phenobarbital can increase liver size in rodents (Lake 2009) and humans (Pirttiaho et al. 1978; Pirttiaho et al. 1982 ), signiWcant species diVerences in both the hyperplasia-inducing properties of phenobarbital and other compounds have been demonstrated.”
BackgroundNakamura, T., Ito, Y., Yanagiba, Y., Ramdhan, D. H., Kono, Y., Naito, H., Hayashi, Y., Li, Y., Aoyama, T., Gonzalez, F. J., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.09.004 · Cited by 57 · cited 3×
“As stated in the introduction, PFOA has been conWrmed to activate and to be a ligand for the xenosensor nuclear receptor PPAR (Bjork and Wallace 2009; Maloney and Waxman 1999; Nakamura et al. 2009; Rosen et al. 2008a; Takacs and Abbott 2007; Vanden Heuvel et al. 2006; Wolf et al. 2008).”
BackgroundInfluentialHirose, Y., Nagahori, H., Yamada, T., Deguchi, Y., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S., Isobe, N., Lake, B. G., et al. (2009) · Toxicology · doi:10.1016/j.tox.2009.01.007 · Cited by 56 · cited 1×
“In contrast to eVects in primary cultures of rodent hepatocytes, phenobarbital does not appear to induce replicative DNA synthesis in cultured human hepatocytes (Parzefall et al. 1991; Hirose et al. 2009; Lake 2009).”
BackgroundLiver size and indices of drug metabolism in epileptics.
Pirttiaho, H. I., Sotaniemi, E. A., Ahokas, J., & Pitkänen, U. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb04597.x · Cited by 41
Perfluorooctanoic acid stimulated mitochondrial biogenesis and gene transcription in rats
Walters, M. W., Bjork, J. A., & Wallace, K. B. (2009) · Toxicology · doi:10.1016/j.tox.2009.07.003 · Cited by 39 · cited 1×
“... of genes for which mRNA expression levels are changed in response to dosing with PFOA in mice are regulated by PPAR, and many of those not regulated by PPAR are regulated by CAR (Rosen et al. 2008a, b). In addition, PFOA has been shown to increase mitochondrial mass via mitochondrial proliferation in rats and monk…”
Background
Research works printed but not linked: 1
- Sibinski LJ, Allen JL, Erickson EE (1983) Two year oral (diet) toxicity/carcinogenicity study of fluorochemical FC-143 in rats. Expt. No. 0281CR0012. Available on USEPA Docket AR226–0437-0440. Riker Laboratories, Inc., St. Paul
Cited by
Post, G. B., Cohn, P. D., & Cooper, K. R. (2012) · Environmental Research · doi:10.1016/j.envres.2012.03.007 · Cited by 639
Per- and polyfluorinated substances (PFASs): Environmental challenges
Krafft, M. P., & Riess, J. G. (2015) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2015.07.004 · Cited by 294
Molecular mechanisms of PFOA-induced toxicity in animals and humans: Implications for health risks
Li, K., Gao, P., Xiang, P., Zhang, X., Cui, X., & Ma, L. Q. (2017) · Environment International · doi:10.1016/j.envint.2016.11.014 · Cited by 260
“Elcombe et al. (2010) then demonstrated that CAR and PXR expression was increased in male rats after exposing to APFO in diet for 28 d.”
Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
Bjork, J. A., Butenhoff, J. L., & Wallace, K. B. (2011) · Toxicology · doi:10.1016/j.tox.2011.06.012 · Cited by 259
Self-citationOverview of emerging contaminants and associated human health effects
Lei, M., Zhang, L., Lei, J., Zong, L., Li, J., Wu, Z., & Wang, Z. (2015) · BioMed Research International · doi:10.1155/2015/404796 · Cited by 231
Metadata
- Authors
- Elcombe, C. R., Elcombe, B. M., Foster, J. R., Farrar, D. G., Jung, R., Chang, S.-C., Kennedy, G. L., & Butenhoff, J. L.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- Ineos (United Kingdom) (GB)
- Clariant (Germany) (DE)
- 3M (United States) (US)
- DuPont (United States) (US)
- Corresponding author
- Butenhoff, John L.
- Venue
- Archives of Toxicology
- Published
- 2010-07-08
- Volume
- 84
- Issue
- 10
- Pages
- 787-798
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2005561403
- Cited by
- 96
- References
- 42
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 5 · 2017: 5 · 2016: 8 · 2015: 5 · 2014: 6 · 2013: 3 · 2012: 12
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Topics
- Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
- Keywords
- ammonium perfluorooctanoate, PPARα, hepatocyte hypertrophy, hepatocyte proliferation, hepatomegaly, Wy-14,643, peroxisomal beta-oxidation, CYP4A1, CYP2B1/2, CYP3A1, apoptosis, non-genotoxic carcinogens
- MeSH terms
- Pregnane X Receptor, Constitutive Androstane Receptor, Animals, Body Weight, Caprylates, Cytochrome P-450 Enzyme System, DNA, Environmental Pollutants, Fluorocarbons, Hepatomegaly, Hypertrophy, Liver, Male, Organ Size, Receptors, Steroid, Rats, Sprague-Dawley, Apoptosis, Receptors, Cytoplasmic and Nuclear, Peroxisomes, Hepatocytes, PPAR alpha, Cell Proliferation, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.